Summary Syncom BV (Syncom) is a provider of custom synthesis solutions.The company’s activities include synthesis of key building blocks, route scouting services, process research activities and medicinal chemistry services.
Its service portfolio includes contract research services, chiral technology services, medicinal chemistry services and analytical services.The company also offers customized service such as synthesize metabolites, impurities, reference standards and stable labelled compounds.
The company’s services support both the pharmaceutical and chemical industries across the globe.Its chiral technologies include resolution of racemates, chiral chromatography, preferential crystallization, chiral pool synthesis, conglomerate screening and enzymatic catalysis.
Syncom is headquartered in Groningen, the Netherlands.
Syncom BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
411 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2021
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer...
The global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
Enterprise ICT Investment Trends in Pharmaceuticals Sector, 2021 Update Summary According to Information & Communication Technology (ICT) decision makers survey, the largest share of enterprise ICT budget in the pharmaceuticals sector for 2020 was allocated to ’production, procurement and operations’...
The Global Chromatography Software Market size is expected to reach $1.6 billion by 2027, rising at a market growth of 9.7% CAGR during the forecast period. Chromatography is the procedure of segregating various components of a mixture based on the relative amounts of every component or solute distributed between a moving fluid stream, known...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
The Global Microbiome Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Microbiome partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Microbiome partnering deals Disclosed headlines, upfronts, milestones and royalties by...
The global curcumin market grew at a CAGR of around 9% during 2015-2020. Looking forward, the analyst expects the market to exhibit strong growth during the next five years. Curcumin is a yellow-colored, naturally occurring bioactive compound commercially extracted from the dried rhizome of the turmeric plant....
The global biologics market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 9% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different...
The Global Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.